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Metallic orthopaedic implants have been successfully used for decades but they have 
serious shortcomings related to their osseointegration and the fact that their mechanical 
properties do not match those of bone.  This paper reviews recent advances in the 
fabrication of novel coatings to improve implant osseointegration and in the development 
of a new generation of hybrid organic-inorganic implant materials specifically designed 




The number of orthopedic surgeries performed worldwide is growing 10 to 12% 
annually. [1] As these procedures become more popular, and patients desire to lead more 
active lives, these rates are expected to increase. An estimated 11 million people in the 
U.S. have at least one medical-device implant and more than $50 billion are spent 
annually on reconstructive devices.[2] In 2003 alone, more than 700,000 dental implant 
procedures were performed in the U.S., and more than 1.3 million in Europe;[3] sales in 
2003 for implants and devices were $8.7 billion and are expected to rise at an annual 
growth rate of 12.5% and reach $17.9 billion by 2009.[1]  Current commercial implants 
are fabricated using materials typically developed for other engineering applications, and 
their osseointegration and long-term stability are still a source of concern. The National 
Center for Health Statistics reports that nearly 15% of the hip replacement surgeries 
performed in 2002 were to revise original replacements,[4] and this number is likely to 
increase as younger people undergo these procedures. These numbers emphasize the need 
for a coordinated research effort to provide patients and doctors with better and more 
durable implants. A short- to medium-term solution is the modification of implant 
surfaces to enhance bonding to bone. In the long term, new implant materials—materials 
that will match the mechanical properties of bone and be actively integrated and 
remodeled by the body—should be developed. This paper reviews some of the recent 
efforts in the development of bioactive glass coatings to enhance the osseointegration of 
metallic and ceramic implants, and the most recent research in the field of organic-







Metals have been used successfully for decades in fracture fixation, joint replacement, 
and dental applications.[5] More recently, high-strength technical ceramics are also being 
considered for the fabrication of orthopedic implants.[6] In many cases, surface treatments 
are used to improve the materials’ bonding ability to living tissues, particularly bone. 
Different approaches are under investigation, including texturing or chemical 
modification of the surfaces to enhance cell attachment, large-scale roughening to 
promote bone ingrowth with the result of an improved mechanical bonding, or applying 
calcium phosphate coatings by different methods to create osteophilic surfaces that will 
bond chemically to the bone.[7]  The most popular coating procedure is plasma spray.[7] 
Plasma-sprayed coatings are now commercially available, and numerous studies have 
shown that they enhance interfacial attachment to bone tissue over short periods of time, 
and promote the formation of a more reliable interface with bone than mechanical 
osseointegration.[7] However, the calcium phosphate coatings fabricated by plasma spray 
have severe drawbacks that include: (1) cracking and unreliable adhesion; (2) variability 
during processing in terms of resulting phases (typically, the coatings consist of a mixture 
of phases, some of them highly soluble amorphous calcium phosphates), morphology, 
thickness, and stresses; (3) significant degradation in the fatigue resistance and endurance 
strength of the implant alloy, and (4) inability to systematically change the coating 
attributes.[5,7] 
 
Clearly, bioactive coatings can improve implant performance, but we are still far from the 
development of optimum materials and fabrication technologies. Ideally, the coatings 
should be tailored to exhibit prescribed biological attributes for each specific application. 
They should have strong adhesion to the implant and good fixation to bone. Their 
composition and microstructure should be controlled such that their dissolution rates 
match the in vivo healing process. The coatings could also serve as templates for the in 
situ delivery of drugs and growth factors at the required times. Most likely this will not 
be achieved by using a single procedure or material, but by combining several of them to 
fabricate layers that blend organic and inorganic phases, with thicknesses ranging from 
hundreds of microns to the nanometer level, and chemically and topographically textured 
surfaces.  
 
The potential of bioactive glass coatings was recognized since the discovery of the 
original Bioglass® composition by Hench.[8]  Bioglass® has excellent bioactivity and 
could be used to enhance the adhesion of the implant to the bone. The development of 
bioactive glass coatings could take advantage of the extensive accumulated experience on 
glass-metal bonding and sealing. Furthermore, the glass properties can be easily adjusted 
from bioactive to bioresorbable or bioinert by controlling their composition.[8] This 
creates the possibility of fabricating layers with finely tuned properties. However, initial 
attempts to coat metallic implants with the original Bioglass® were marred by the 
generation of large thermal expansion stresses and high reactivity between the metal and 
the glass.[9] Subsequently, several techniques have been investigated for the preparation 
of glass coatings, such as enameling, plasma spray, RF sputtering, sol-gel, pulsed-laser 
deposition (PLD), and others. Although it has been possible to deposit glass layers that 
retain bioactivity, a recurrent problem is the control of the glass-metal reactions to 
achieve good coating adhesion, and the generation of large thermal stresses during 
processing that can cause cracking and/or delamination of the coating. The solution to the 
problem requires the development of coating procedures and novel bioactive glasses, and 
glass-ceramics, with adequate thermal expansion coefficients and softening points. 
 
Figure 1. (a) Environmental SEM showing a cross section of a graded glass coating 
after a 6-month in vivo test in a pig model. The coating survived, maintaining excellent 
adhesion to the implant. A corroded layer can be observed on the coating surface 
providing adhesion to the bone, but the high-silica layer in contact with the alloy remains 
intact, maintaining good adhesion to the metal. Preliminary tests indicate that, after 6 
months, the bone matrix in the vicinity of the bone-implant interface of coated implants 
had changed to lamellar-type bone, while the uncoated implants remained with woven-
type bone. It is reasonable to assume that the coated device had less micromovement, 
so that the biomechanical integration of the device to the surrounding bone tissues was 
achieved earlier during the experimental period, facilitating the transformation of woven-
bone matrix to lamellar type over a 2- to 6-month time period. (b) During indentation 
tests, the cracks do not propagate at the glass/metal interface, indicating good coating 
adhesion achieved through the formation of a thin (100-150 nm) Ti5Si3 layer that can be 
observed using high-resolution TEM. 
 
Since the discovery of Bioglass®, other bioactive glass compositions have been reported 
in the literature. In our laboratory, we have demonstrated that a new family of bioactive 
glasses, in the system Si-Ca-Mg-Na-K-P-O, presents thermal expansion coefficients close 
to those of the metallic alloys used in orthopedic implants.[10] This is achieved through 
the partial substitution of Ca by Mg, and of Na by K. These glasses have adequate 
softening points to be used in the fabrication of coatings by a simple enameling 
technique. Strong glass/metal adhesion is achieved through the formation of thin 
interfacial layers. The procedure can be extended to fabricated graded coatings through 
the sequential deposition of different glass and glass-ceramic layers. For example, we 
have fabricated graded coatings on Ti and Co-Cr alloys consisting of a high-silica glass in 
contact with the metal, and a composite surface layer that consists of a mixture of a low-
silica glass with synthetic hydroxyapatite (HA) particles (Figure 1). The high-silica layer 
is very resistant to corrosion in body fluids; it provides good coating adhesion and long-
term stability, while the surface layer is designed to enhance coating attachment to the 
tissue (Figure 1). 
 
  
Figure 2. Surface of a thin glass coating deposited on Ti6Al4V by PLD, as prepared and 
after annealing for 30 s at 700 °C. The coating is thin and the substrate peaks are visible 
in the EDS analysis. Quantitative analysis indicates that the stoichiometry of the layer is 
in ±5 wt% of the original glass target. 
  
Techniques such as enameling or plasma spray can be used to fabricate relatively thick 
layers, typically 50 to 200 µm. However, the driving force for coating cracking and 
delamination increases with coating thickness; thinner layers could withstand much larger 
thermal stresses and have a wider range of compositions. Perhaps two of the most 
researched techniques for the fabrication of thin bioactive glass layers are sol-gel and 
pulsed-laser deposition.[11,12] Both techniques can be adapted to the fabrication of 
multilayered coatings. However, the fabrication of glass layers with complex 
compositions by sol-gel could be problematic. On the other hand, PLD can be used to 
prepare thin films of any material, including complex ceramics and glasses, while 
maintaining coating stoichiometry (Figure 2). In PLD, a high-power laser is focused onto 
a target. The extreme energy density at the focus breaks many chemical bonds, and a few 
surface layers are ejected at high kinetic energy in the form of an ablation “plume.” The 
components of these layers travel ballistically across the vacuum chamber until they 
strike a substrate material. The high-impact energies (typically 100 eV) cause the 
particles to stick to the surface and be compressed, forming a dense continuous film. PLD 
can be used to deposit highly bioactive and hygroscopic glasses, or glasses with very high 
softening points that cannot be applied by other methods. By controlling the target 
temperature, or annealing after deposition, coating adhesion and surface roughness can be 
manipulated. It has been observed that the implant surface texture affects cell attachment 
and osseointegration. Rapid prototyping techniques such as ink-jet printing or 
robocasting can be used to fabricate textured glass coatings (Figure 3). These techniques 
can also be used to integrate organic materials into coatings to serve as templates for the 
delivery of drugs and growth factors. 
 
Glass-based coatings offer a unique versatility; they can be applied using a wide range of 
techniques, and their composition—and therefore their properties—can be easily 
manipulated. It is well known that bioactive glasses can generate hydroxyapatite (a 
calcium phosphate closely related to the mineral component of the bone) in vivo though a 
complex dissolution-precipitation process. The interaction of glass coatings with tissue 
can be further manipulated by designing appropriate surface textures. Furthermore, in 
vitro analysis in cell cultures has shown that bioactive glasses and coatings can indirectly 
affect osteoblast gene expression through their dissolution products. Quantitative real-
time RT-PCR (reverse transcription-polymerase chain reaction) analysis showed that 
silicate glass coating extract induced a twofold expression of Runx-2, a key marker of 
osteoblast differentiation, compared to Ti-6Al-4V and tissue culture polystyrenes. Future 
investigation should address the identification of specific chemical cues behind the 




Figure 3. Textured glass coating surface 
printed on Ti6Al4V using robotic assisted 
deposition. The glass belongs to the Si-Ca-
Mg-Na-K-P-O and has a silica content of 
53 wt%. The ink has a 70 wt% content of 
glass dispersed in ethanol, with 0.8 wt% of 
a dispersant (Mellorian 312, CECA S.A.), 
2.5 wt% Methocell F4M (7.3 wt% in water), 
and 0.5 wt% polyethilenimine. 
 
Bonelike Composites 
Even if the use of coatings can improve their osseointegration, current implants still have 
a fundamental flaw: they are foreign objects stiffer than bone. Consequently, the implants 
bear a greater proportion of the load than the surrounding skeleton, shielding it from its 
normal stress level. The osteoblasts are not stimulated into generating new bone, the 
tissue is resorbed and the implant becomes loose over time, limiting its life. Thus, an 
ideal solution, and a scientific challenge, is to develop bone-like biomaterials that will be 
treated by the host as normal tissue matrices, and induce cell penetration and proliferation 
after implantation, while their properties match those of the tissue to be repaired. These 
adaptive biomaterials will integrate with bone tissue while they are actively resorbed or 
remodeled in a programmed way, with controlled osteogenic activity. Such implants 
could also act as drug delivery systems by releasing drugs and/or stimulating the growth 
of new bone tissue at the fracture site by slowly releasing bone growth factors (e.g., bone 
morphogenic protein or transforming growth factor-β) throughout its degradation 
process. This is an optimal solution if the requirements of strength and performance can 
be met, since natural tissues can replace and repair themselves. To accomplish this, the 
strength and stability of the material-tissue interface should be maintained while the 
material is resorbed or remodeled, and its resorption and remodeling rates should be 
matched to the tissue repair rates, which can vary enormously with tissue type or patient 
age. It is also important that biodegradation of the resorbable material results only in 
production of metabolically acceptable substances. The materials will then take 
advantage of the biological principles of bone repair that have been developed over 
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Figure 4. Urea-mediated solution mineralization of hydroxyapatite (HA) onto pHEMA 
hydrogel scaffolds. Thermo-decomposition of urea produces a gradual increase in pH, 
resulting in the hydrolysis of surface 2-hydroxyethyl esters and the precipitation of HA 
from the aqueous solution. The in situ generated surface carboxylates strongly interact 
with calcium ions and facilitate the heterogeneous nucleation and 2-dimensional growth 
of a high-affinity calcium-phosphate (CP) layer on the pHEMA surface. Prolonged 
mineralization allows for the growth of a thicker CP layer that covers the entire hydrogel 
surface. The SEM microcraph on the right shows the 2-dimensional circular outward 
growth of a calcium apatite layer from multiple nucleation sites on the acidic surface of 
pHEMA. The calcium phosphate layer did not delaminate, even after Vickers indentation 
with a load of 5 N (bottom micrograph).   
 
The challenge can be matched with the use of organic-inorganic composites that will 
combine the toughness of the organic phase with the stiffness of the inorganic material. 
The adequate combination of biodegradable polymers and ceramics can be used to 
manipulate the resorption of the composite. However; fabrication of those materials has 
proved difficult. Several groups have reported the fabrication of organic-inorganic 
composites by mixing biodegradable polymers such as poli-L-lactide with micron-sized 
hydroxyapatite particles.[13] Whereas some of these materials have interesting properties, 
very often the composites are marred by low elastic modulus, poor mechanical properties, 
or fast degradation in the biological environment.[14]  It is necessary to develop novel 
processing routes where the material microstructure can be controlled from the nano to 
the meso level. In this way, the structure of natural bone can be used as a blueprint for the 
design of new materials.   
 
Structurally, natural bone is a composite of collagen, a protein-based hydrogel template, 
and inorganic dahilite (carbonated apatite) crystals. The microstructural design of bone, 
combined with the controlled integration of the organic and inorganic components, 
provides unique properties: low density and stiffness, and relatively high strength and 
toughness. Throughout the cavities of bone, there are bone cells and a myriad of soluble 
factors and extracellular matrix components that are constantly involved in the bone 
remodeling process. Bone biogenesis is thought to occur by templated mineralization of 
hard apatite crystals by the elastic collagen scaffold, a process that several research 
groups have sought to emulate by the synthetic biomimetic mineralization of different 
organic materials. For example, hydroxyapatite crystals have been grown on collagen 
scaffolds using mineralizing solutions. However, reports of the final properties of these 
materials are scarce.[15] Most of them seem to lack the level of organic-inorganic 
integration observed in real bone. On the other hand, Hartgerink et al.[16] have 
demonstrated that peptide-amphilides can self-assemble to form fibrous scaffolds that 
will template the mineralization of HA in a way that mimics the alignment between 
collagen fibrils and apatite crystals in bone.   
 
A particularly appealing candidate for the design of highly functional organic scaffolds 
for mineralization is hydrogel polymers. The intrinsic elasticity and water retention 
ability of synthetic hydrogels resemble those of collagen, and their porosity may be 
controlled by various techniques. Another important feature of hydrogels is that they can 
be assembled in 3-dimensional form, displaying multiple functional domains through 
copolymerization of different monomers. The polymerization chemistry is water 
compatible, allowing incorporation of polar ligands such as anionic peptides that mimic 
the acidic matrix proteins regulating mineral growth, and biological epitopes such as the 
tripeptide RGD that promote cellular adhesion. Observations have shown that pHEMA-
based hydrogel copolymers can be mineralized in a way that provides very strong 
polymer-mineral interfacial adhesion.[17,18] The mineralization method takes advantage of 
the dramatically different solubilities of HA in acidic and basic aqueous solutions, and 
the chemically labile nature of ester groups of pHEMA in basic solutions. Thermo-
decomposition of urea in aqueous media was used as a facile pH modulator to generate 
an anionic surface and partially acidic interior of the pHEMA gel (Figure 4). This 
initiated the heterogeneous nucleation and high-affinity growth of calcium apatite on the 
gel surface, and extensive calcification inside the gel. The intrinsic chemical nature of the 
hydrogel surface (the in situ generation of surface carboxylates that strongly bind to 
calcium ions) dictates the high-affinity template-driven mineralization observed with a 
strong hydrogel-mineral adhesion (Figure 4). In addition, cross-linked 
polymethacrylamide and polymethacrylate hydrogels can be functionalized with mineral-
binding ligands and used to template the formation of hydroxyapatite. Strong adhesion 
between the organic and inorganic materials can be achieved for hydrogels functionalized 
with either carboxylate or hydroxy ligands.[17] The mineral-nucleating potential of 
hydroxyl groups identified here broadens the design parameters for synthetic bonelike 
composites and suggests a potential role for hydroxylated collagen proteins in bone 
mineralization. Human osteoblastic cells were found to attach, spread, and proliferate on 
all synthetic hydrogel copolymers tested, with no apparent cytotoxicity. 
 
Figure 5. Schematic of the robocasting process a computer aided design technology for 
the free-form fabrication of ceramic scaffolds. A ceramic slurry is extruded through a thin 
nozzle to build a part layer by layer following a computer design. The slurry must exhibit 
a controlled viscoelastic response. It should flow through the nozzle and subsequently 
settle very fast, bonding to the previous layer so that the part maintains its shape while 
printing. The slurries should contain a high solid fraction (typically between 40 to 60 
wt%)  to minimize drying-induced shrinkage after assembly. The insets show a HA grid 
fabricated by robocasting. 
 
A reverse approach is to fabricate porous ceramic scaffolds, with controlled 
microstructure, as the base for the fabrication of dense organic-inorganic composites 
through infiltration with polymers. Techniques for the fabrication of porous inorganic 
materials are well developed, and with the advent of the so-called solid-free-form 
fabrication technologies, or rapid prototyping technologies, we can now custom design 
and produce porous scaffolds directly from a computer-aided design (CAD) model with 
determined shapes and porosities (Figure 5).[19] These techniques produce 3-D objects 
guided by a CAD file, as well as digital data produced by an imaging source such as 
computed tomography (CT) or magnetic resonance imaging (MRI), opening the door for 
the fabrication of custom-designed implants. Gradients in material porosity, as well as 
sequential infiltration of polymers with different resorbability, can be used to further 
manipulate the material resorption rate. 
Both strategies have their advantages. While biomineralization of organic scaffolds is a 
process closer to the formation of natural bone, starting from porous inorganic materials 
could be a shorter route to the fabrication of novel biomaterials customized for diverse 
applications. These materials can also be tailored for systematic in vitro and in vivo 
studies that will reveal the mechanisms of implant fixation and durability, and correlate 




The initial search for strong orthopedic materials led to the use of bioinert alloys or 
ceramics. These implants have improved the lives of thousands of patients worldwide, 
and will probably be used for a long time. However, most implant limitations are still 
material related. Two important concerns are their osseointegration and their extreme 
stiffness. Glass coatings can be a viable alternative to current surface treatments used to 
improve implant adhesion to bone. The composition of the glasses can be adjusted in 
order to modulate coating properties. Different techniques can be used in order to 
fabricate coatings with a wide range of thickness, texture, and gradient. The glasses could 
be combined with other organic or inorganic materials to tune the coating resorption rates 
or to fabricate therapeutic coatings. However, it is necessary to develop new materials 
specifically designed for orthopedic applications. This challenge could be met by novel 
hybrid organic/inorganic composites with an architecture controlled from the nano to the 
mesolevels. The development of coatings and materials is intimately related, and the 
lessons learned in one field can be applied in the other. Fundamental research is 
necessary to develop novel compositions and fabrication techniques, and to better 
understand the microstructural parameters that control the materials’ response in vitro 
and in vivo. A key component of the effort should be the analysis of structure and 
adhesion at both the internal material interfaces (glass-metal, polymer-ceramic) and the 
implant-tissue interface. This development can only take place through an 
interdisciplinary effort combining materials scientists, chemists, physicists, biologists, 
and clinicians. The end result will not only be better biomaterials, but a better 
understanding of the natural tissues, and lessons that can be applied to the fabrication of 
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